Recently added

Efficacy and safety of bintrafusp alfa evaluated in a phase II single-arm clinical trial in previously treated advanced pleural mesothelioma

Benitez, Jose Carlos; Sala, Maria Ángeles; Álvarez, Carlos; Nadal, Ernest; Martin Martorell, Paloma; cedres, susana (Elsevier, 2025-05)

Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer

Wang, Changli; Awad, Mark; Forde, Patrick; Girard, Nicolas; Spicer, Jonathan; Lu, Shun; FELIP, ENRIQUETA (American Society of Clinical Oncology, 2025-04-20)

AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular

Castaño-Díez, Sandra; Zugasti, Ines; Calvo, Xavier; Schulz, Felicitas; Avendaño, Alejandro; Palomo Sanchis, Laura; POMARES, HELENA; Vila Bou, Jordi; Lopez-Guerra, Monica (American Society of Hematology, 2025-01-14)

Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial

Soler-Gonzalez, Gemma; taieb, julien; Fakih, Marwan; Tabernero, Josep; Ciardiello, Fortunato; Van Cutsem, Eric (Elsevier, 2025-06)

Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI: Part 2—Ex vivo imaging: Added value and acquisition

Ianus, Andrada; Hansen, Brian; Barrett, Rachel Laura Coopersmith; Schilling, Kurt; Grussu, Francesco; Howard, Amy (Wiley, 2025-06)

Scientia. Department of Health Digital Information Depot

VHIO - Articles científics: Recent submissions

Efficacy and safety of bintrafusp alfa evaluated in a phase II single-arm clinical trial in previously treated advanced pleural mesothelioma

Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer

AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular

Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial

Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI: Part 2—Ex vivo imaging: Added value and acquisition

Scientia. Department of Health Digital Information Depot

VHIO - Articles científics: Recent submissions

Efficacy and safety of bintrafusp alfa evaluated in a phase II single-arm clinical trial in previously treated advanced pleural mesothelioma ﻿

Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer ﻿

AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular ﻿

Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial ﻿

Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI: Part 2—Ex vivo imaging: Added value and acquisition ﻿

Efficacy and safety of bintrafusp alfa evaluated in a phase II single-arm clinical trial in previously treated advanced pleural mesothelioma

Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer

AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular

Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial

Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI: Part 2—Ex vivo imaging: Added value and acquisition